2.0
Mar 30, 2021
Current employee, more than 10 years
Londres, Inglaterra
Recommend
CEO approval
Business Outlook
Pros
Excellent colleagues / scientists, great collaborations via matrix teams and via external partnerships to boost drug discovery
Cons
Change in culture/values, very poor senior leadership (CEO and LT), clunky over-complex systems, lack of agility